tiprankstipranks
Balchem Corp. (BCPC)
NASDAQ:BCPC
Holding BCPC?
Track your performance easily

Balchem (BCPC) Earnings Date & Reports

152 Followers

Earnings Data

Report Date
Feb 14, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$1.11
Last Year’s EPS
$0.95
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Oct 25, 2024
|
% Change Since: -0.40%
|
Next Earnings Date:Feb 14, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong overall financial performance with record earnings and growth in key segments, despite challenges in the Animal Nutrition & Health segment and increased costs. The company's focus on innovation and debt reduction further contributed positively.
Company Guidance
During Balchem's Q3 2024 earnings call, the company reported strong financial performance with consolidated revenues of $240 million, marking a 4.3% increase from the previous year. Gross margin dollars rose by 11.5%, and the gross margin percentage expanded by 230 basis points to 35.6%. Earnings from operations reached a record $48 million, up 10% year-over-year, and adjusted EBITDA climbed to $64 million, reflecting a 7.6% growth with an adjusted EBITDA margin of 26.8%. The company also recorded a net income of $34 million, an increase of 16.4%, resulting in earnings per share of $1.03 on a GAAP basis and $1.13 on a non-GAAP basis. Additionally, cash flows from operations were $51 million, with free cash flow amounting to $42 million. Balchem's Human Nutrition & Health segment led the growth, complemented by a strong performance in Specialty Products, which offset the challenges in the Animal Nutrition & Health segment. The company emphasized its continued focus on innovation and new product launches, which are expected to bolster future growth.
Strong Financial Performance
Balchem reported a strong quarter with consolidated revenues of $240 million, an increase of 4.3% compared to the prior year. Gross margin dollars grew 11.5%, and the gross margin percentage expanded by 230 basis points to 35.6%.
Record Earnings
Earnings from operations reached $48 million, a 10% increase versus the prior year, with record adjusted EBITDA of $64 million, up 7.6%.
Human Nutrition & Health Segment Growth
The Human Nutrition & Health segment generated sales of $152 million, an increase of 5.4% from the prior year, driven by higher sales within the minerals and nutrients business and the food and beverage markets.
Innovative Product Launches
New products include AminoShure-XL in Animal Nutrition & Health and K2VITAL DELTA Fermented and VitaCholine Pro-Flo in Human Nutrition & Health, highlighting ongoing innovation.
Debt Reduction
Balchem reduced its debt by $40 million in the third quarter, ending with net debt of $153 million and a leverage ratio of 0.6.
---

Balchem (BCPC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BCPC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 14, 20252024 (Q4)
1.10 / -
0.95
Oct 25, 20242024 (Q3)
1.11 / 1.13
1.048.65% (+0.09)
Jul 26, 20242024 (Q2)
1.03 / 1.09
1.062.83% (+0.03)
May 03, 20242024 (Q1)
0.98 / 1.03
0.949.57% (+0.09)
Feb 16, 20242023 (Q4)
0.93 / 0.95
0.941.06% (+0.01)
Oct 27, 20232023 (Q3)
0.97 / 1.04
14.00% (+0.04)
Jul 28, 20232023 (Q2)
0.84 / 1.06
1.07-0.93% (-0.01)
Apr 28, 20232023 (Q1)
0.72 / 0.94
1.03-8.74% (-0.09)
Feb 24, 20232022 (Q4)
0.80 / 0.94
0.8510.59% (+0.09)
Nov 04, 20222022 (Q3)
0.94 / 1.00
0.928.70% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

BCPC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 25, 2024$166.16$171.46+3.19%
Jul 26, 2024$174.81$180.78+3.42%
May 03, 2024$146.28$150.40+2.82%
Feb 16, 2024$146.39$149.20+1.92%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Balchem Corp. (BCPC) report earnings?
Balchem Corp. (BCPC) is schdueled to report earning on Feb 14, 2025, TBA Not Confirmed.
    What is Balchem Corp. (BCPC) earnings time?
    Balchem Corp. (BCPC) earnings time is at Feb 14, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BCPC EPS forecast?
          BCPC EPS forecast for the fiscal quarter 2024 (Q4) is $1.11.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis